 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 161 - 170 of 2154:
Bill to Force FDA Tobacco Regulation Moves Through Energy and Commerce
An increasingly bipartisan bill that would require the Food and Drug Administration to regulate tobacco products advanced from a House panel on Wednes...
Bill Would Put Tobacco Under FDA Control
In what appears to be the best chance since public health groups started pushing for it in the 1970s, Congress is poised to regulate tobacco, a produc...
BioE receives FDA approval for device used to process umbilical cord blood
BioE Inc. announced Wednesday that it has received approval from the U.S. Food and Drug Administration for its PrepaCyte—CB Processing System, which i...
Biogen Idec, GlaxoSmithKline warned by FDA about Internet ads
Biogen Idec and GlaxoSmithKline are among 14 companies that have received warning letters from the U.S. Food and Drug Administration cautioning the co...
BioMarin reports receipt of FDA approval for Kuvan for PKU
BioMarin Pharmaceutical, a provider of biopharmaceuticals for serious diseases and medical conditions, declared on 13 December that the company has re...
BioMedical Enterprises receives FDA clearance on new device
The Food and Drug Administration (FDA) approved BioMedical Enterprises Inc.'s new spinal product to market. The local company received FDA 510(k) ...
Biopure talks with FDA about clinical trial for Hemopure
Biopure Corp. has been in talks with the Food and Drug Administration about plans to run a clinical trial of its Hemopure product. If those discussion...
BioSante says FDA special protocol assessment for LibiGel completed
BioSante Pharmaceuticals Inc. (NASDAQ:BPAX) said Tuesday that it reached and completed a special protocol assessment with the Food and Drug Administra...
Biotechnology Industry Seeks Passage of Bill To Allow FDA Approval of Generic Biotech Medications
The biotechnology industry, which for years has opposed bills that would allow FDA to approve generic versions of biotech medications, has made such l...
Biotechs Taking Added Care in Filings Now That FDA, SEC Can Share Info
During the last several years, the Securities and Exchange Commission has been taking a closer look at filings and investor communications by public ... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |